D. González

480 total citations
14 papers, 291 citations indexed

About

D. González is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Radiation. According to data from OpenAlex, D. González has authored 14 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Radiation. Recurrent topics in D. González's work include Prostate Cancer Treatment and Research (6 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Advanced Radiotherapy Techniques (4 papers). D. González is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Advanced Radiotherapy Techniques (4 papers). D. González collaborates with scholars based in Netherlands, Colombia and Belgium. D. González's co-authors include Jens Overgaard, Giorgio Arcangeli, Søren M. Bentzen, Maarten C.C.M. Hulshof, M. Bolla, Harry Bartelink, D. J. Gouma, J.C. Horiot, M. van Glabbeke and M.F. Gerhards and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

D. González

13 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. González Netherlands 6 144 109 87 55 47 14 291
Silvia Gómez Switzerland 7 205 1.4× 68 0.6× 111 1.3× 27 0.5× 25 0.5× 12 354
M. Cristescu United States 12 88 0.6× 88 0.8× 70 0.8× 91 1.7× 28 0.6× 23 341
Emmanuel Mbalisike Germany 11 135 0.9× 78 0.7× 153 1.8× 52 0.9× 43 0.9× 17 334
S. Oldenborg Netherlands 12 164 1.1× 139 1.3× 94 1.1× 43 0.8× 29 0.6× 16 366
Joost W. Wijlemans Netherlands 11 153 1.1× 45 0.4× 116 1.3× 141 2.6× 35 0.7× 15 374
Christina Armpilia Greece 9 67 0.5× 160 1.5× 145 1.7× 38 0.7× 144 3.1× 30 353
Romain Bréguet Switzerland 11 88 0.6× 59 0.5× 96 1.1× 160 2.9× 17 0.4× 27 386
Enrique Estrada-Lobato Austria 8 84 0.6× 89 0.8× 148 1.7× 52 0.9× 13 0.3× 18 339
Qiaoying Hu China 12 60 0.4× 86 0.8× 75 0.9× 100 1.8× 17 0.4× 27 311
M. Willemijn Kolff Netherlands 10 111 0.8× 148 1.4× 91 1.0× 35 0.6× 33 0.7× 20 343

Countries citing papers authored by D. González

Since Specialization
Citations

This map shows the geographic impact of D. González's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. González with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. González more than expected).

Fields of papers citing papers by D. González

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. González. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. González. The network helps show where D. González may publish in the future.

Co-authorship network of co-authors of D. González

This figure shows the co-authorship network connecting the top 25 collaborators of D. González. A scholar is included among the top collaborators of D. González based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. González. D. González is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Gupta, Shilpa, Amee Morgans, Luke T. Nordquist, et al.. (2025). Long-term safety outcomes of 177 Lu-PSMA-617 in patients with prostate cancer.. Journal of Clinical Oncology. 43(5_suppl). 1 indexed citations
2.
González, D., et al.. (2025). Cancer genomics and bioinformatics in Latin American countries: applications, challenges, and perspectives. Frontiers in Oncology. 15. 1584178–1584178. 1 indexed citations
3.
González, D., et al.. (2024). HER2-low prevalence among Hispanic/Latino women with breast cancer: A systematic review and meta-analysis. PLoS ONE. 19(12). e0315287–e0315287. 1 indexed citations
4.
González, D., et al.. (2023). Single Nucleotide Polymorphisms Associated with Prostate Cancer Progression: A Systematic Review. Cancer Investigation. 42(1). 75–96. 1 indexed citations
5.
Horiot, J.C., W. Van den Bogaert, K. Kian Ang, et al.. (2015). European Organization for Research on Treatment of Cancer Trials Using Radiotherapy with Multiple Fractions per Day. Frontiers of radiation therapy and oncology. 22. 149–161. 3 indexed citations
6.
Sclafani, Francesco, D. González, David Cunningham, et al.. (2013). TP53 status may predict benefit from cetuximab in high-risk, locally advanced rectal cancer: Results of the EXPERT-C trial. European Journal of Cancer. 49. 5 indexed citations
7.
Macías, David, D. González, David Gallardo, et al.. (2008). PHASE II STUDY OF HYPOFRACTIONATED RADIOTHERAPY (HYPORT) IN LOCALISED PROSTATE CANCER: REPORT ON ACUTE AND 18 MONTH LATE TOXICITY. European Urology Supplements. 7(3). 117–117. 1 indexed citations
8.
Gerhards, M.F., et al.. (2000). Prevention of implantation metastases after resection of proximal bile duct tumours with pre-operative low dose radiation therapy. European Journal of Surgical Oncology. 26(5). 480–485. 27 indexed citations
9.
Bolla, M., Laurence Collette, D. González, et al.. (1999). 5 Long term results of immediate adjuvant hormonal therapy with goserelin in patients with locally advanced prostate cancer treated with radiotherapy. A phase III EORTC study. International Journal of Radiation Oncology*Biology*Physics. 45(3). 147–147. 15 indexed citations
10.
Bolla, M., Laurence Collette, D. González, et al.. (1999). Long term results of immediate adjuvant hormonal therapy with goserelin in patients with locally advanced prostate cancer treated with radiotherapy — A phase III EORTC study. European Journal of Cancer. 35. S82–S82. 27 indexed citations
11.
12.
13.
Bolla, M., Harry Bartelink, G. Garavaglia, et al.. (1995). EORTC guidelines for writing protocols for clinical trials of radiotherapy. Radiotherapy and Oncology. 36(1). 1–8. 40 indexed citations
14.
Bolla, M., Harry Bartelink, G. Garavaglia, et al.. (1995). Eortc guidelines for writing protocols for clinical trials of radiotherapy. Medical dosimetry. 20(4). 312–312.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Gómez Breakdown of academic impact, for papers by M. Cristescu Breakdown of academic impact, for papers by Emmanuel Mbalisike Breakdown of academic impact, for papers by S. Oldenborg Breakdown of academic impact, for papers by Joost W. Wijlemans Breakdown of academic impact, for papers by Christina Armpilia Breakdown of academic impact, for papers by Romain Bréguet Breakdown of academic impact, for papers by Enrique Estrada-Lobato Breakdown of academic impact, for papers by Qiaoying Hu Breakdown of academic impact, for papers by M. Willemijn Kolff
Rankless by CCL
2026